200 studies found for:    "Osteoporosis, Postmenopausal"
Show Display Options
RSS Create an RSS feed from your search for:
"Osteoporosis, Postmenopausal"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2 transdermal (Julina, BAY86-5435)
2 Completed Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
Condition: Osteoporosis, Postmenopausal
Intervention: Other: OPSAT-Q
3 Completed 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Teriparatide;   Drug: Raloxifene
4 Completed Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: ibandronate, calcium and vitamin D;   Drug: placebo,calcium and vitamin D
5 Completed Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
Conditions: Postmenopausal Osteoporosis;   Compliance
Interventions: Drug: Raloxifene;   Drug: Strontium ranelate
6 Completed Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2 transdermal (Julina, BAY86-5435)
7 Completed Study With AMG 785 to Treat Japanese Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis (PMO)
Interventions: Drug: AMG 785;   Drug: Placebo
8 Completed Risedronate Sodium in Post Menopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate sodium
9 Completed Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: Teriparatide
10 Completed Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan
Condition: Post Menopausal Osteoporosis
Intervention:
11 Completed
Has Results
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 162;   Drug: Placebo
12 Completed
Has Results
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women
Condition: Postmenopausal Osteoporosis
Interventions: Drug: menatetranone;   Drug: alfacalcidol
13 Unknown  Study on the microRNA Expression Level in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: osteoporosis
14 Enrolling by invitation Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: Observation
15 Completed A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
Condition: Postmenopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
16 Completed A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Alendronate;   Drug: Ibandronate
17 Completed BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
18 Completed A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Ibandronate
19 Completed A Study of Adherence to Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP).
Condition: Postmenopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
20 Completed Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Ibandronate (SB743830HD)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years